Cellectar Biosciences
Stock Forecast, Prediction & Price Target
Cellectar Biosciences Financial Estimates
Cellectar Biosciences Revenue Estimates
Cellectar Biosciences EBITDA Estimates
Cellectar Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $54.14M Low: $18.18M High: $90.09M avg. 0% | Avg: $103.83M Low: $38.09M High: $169.57M avg. 91.79% | Avg: $180.64M Low: $66.27M High: $295.00M avg. 73.96% | Avg: $263.50M Low: $96.68M High: $430.32M avg. 45.87% |
Net Income
% change YoY
| $-23.97M N/A | $-28.60M -19.32% | $-37.98M -32.80% | Avg: $-24.02M Low: $-15.88M High: $6.35M avg. 36.74% | Avg: $21.35M Low: $-4.39M High: $11.85M avg. 188.88% | Avg: $19.00M Low: $3.36M High: $34.64M avg. -11.00% | Avg: $29.41M Low: $5.20M High: $53.62M avg. 54.76% |
EBITDA
% change YoY
| $-24.13M N/A | $-28.81M -19.40% | $-38.76M -34.54% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$4.32 N/A | -$4.05 6.25% | -$3.11 23.20% | Avg: -$0.64 Low: -$1.3 High: $0.52 avg. 79.34% | Avg: $0.22 Low: -$0.36 High: $0.97 avg. 133.72% | Avg: $1.56 Low: $0.28 High: $2.83 avg. 617.68% | Avg: $2.41 Low: $0.43 High: $4.39 avg. 54.76% |
Operating Expenses
% change YoY
| $24.13M N/A | $28.81M 19.40% | $38.96M 35.21% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Cellectar Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 67.34% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -15.88M, average is -24.02M and high is 6.35M.
What is Cellectar Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 52.90% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $18.18M, average is $54.14M and high is $90.09M.
What is Cellectar Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 221.37% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$1.3, average is -$0.64 and high is $0.52.
What is the best performing analyst?
In the last twelve months analysts have been covering Cellectar Biosciences stock. The most successful analyst is Jeff Jones.